Bristol Myers Squibb has experienced a long and successful history on the stock market. Established in 1887, the company has grown from a small chemical manufacturer to a world-leading biopharmaceutical company. Today, Bristol Myers Squibb is a Fortune 500 company with a market cap of over $90 billion. Throughout its long life, Bristol Myers Squibb has been publicly traded on the New York Stock Exchange, and its stock price has varied significantly over time.
Early Years of Bristol Myers Squibb
Bristol Myers Squibb was founded in 1887 by William McLaren Bristol and John Ripley Myers. Initially, the company was a small-scale chemical manufacturer, producing salts, soaps, and other chemical products. By the early 20th century, the company had grown to become a major player in the pharmaceuticals space, and its stock price had begun to rise steadily. Bristol Myers Squibb's stock price rose steadily throughout the early 20th century, reaching a peak of around $90 per share in the mid-1930s.
Bristol Myers Squibb Stock Price During WWII
During World War II, Bristol Myers Squibb's stock price fluctuated significantly. Initially, the stock price rose as the company's production of war-related chemicals and pharmaceuticals increased. However, the stock price dropped sharply in the mid-1940s as the war ended and the company's production shifted back to civilian products. By the end of the war, the stock price had fallen to around $50 per share.
Bristol Myers Squibb Stock Price in the 1950s
The 1950s saw a strong recovery in Bristol Myers Squibb's stock price. The company's sales of civilian products increased steadily during the decade, and its stock price rose to around $90 per share. During this time, Bristol Myers Squibb also began to make a number of major acquisitions, including the purchase of several smaller pharmaceutical companies. This strategy proved successful, and Bristol Myers Squibb's stock price continued to rise throughout the 1950s.
Bristol Myers Squibb Stock Price in the 1960s
In the 1960s, Bristol Myers Squibb's stock price continued to increase steadily. The company's sales of both civilian and military products rose sharply, and its stock price rose to nearly $200 per share. During this time, Bristol Myers Squibb continued to make a number of major acquisitions, and its stock price rose even higher. By the end of the decade, the stock price had reached a peak of around $220 per share.
Bristol Myers Squibb Stock Price in the 1970s
The 1970s saw a significant decline in Bristol Myers Squibb's stock price. The company's sales of civilian products declined as the decade progressed, and its stock price dropped to around $100 per share. This decline was compounded by a series of lawsuits and government investigations into the company's pricing practices. By the end of the decade, the stock price had fallen to around $50 per share.
Bristol Myers Squibb Stock Price in the 1980s
The 1980s saw a dramatic recovery in Bristol Myers Squibb's stock price. The company's sales of civilian products increased, and its stock price rose to around $150 per share. This increase was helped by a series of major acquisitions, including the purchase of a number of smaller pharmaceutical companies. By the end of the decade, the stock price had reached a peak of around $200 per share.
Bristol Myers Squibb Stock Price in the 1990s
The 1990s saw a steady increase in Bristol Myers Squibb's stock price. The company's sales of civilian products grew steadily throughout the decade, and its stock price rose to around $250 per share. This increase was aided by a series of acquisitions and new product launches, and by the end of the decade, the stock price had reached a peak of around $300 per share.
Bristol Myers Squibb Stock Price in the 2000s
The 2000s saw a significant increase in Bristol Myers Squibb's stock price. The company's sales of civilian products continued to grow steadily, and its stock price rose to around $400 per share. This increase was helped by a number of major acquisitions, including the purchase of a number of smaller pharmaceutical companies. By the end of the decade, the stock price had reached a peak of around $600 per share.
Bristol Myers Squibb Stock Price in 2021
Bristol Myers Squibb's stock price has continued to increase in the 2020s. The company's sales of civilian products have continued to grow steadily, and its stock price has risen to around $70 per share. This increase has been helped by a series of major acquisitions, including the purchase of a number of smaller pharmaceutical companies. As of 2021, the stock price is around $90 per share.